Avidity Biosciences stock price
아트리움 테라퓨틱스NASDAQ:RNA · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →Avidity Biosciences last closed at $7.84 (-3.69%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -1.4×. Its overall grade ranks 338 of 739 stocks in Healthcare.
About this company
Avidity Biosciences last closed at $7.84 (-3.69%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B · 338/739
Valuation grade B+
Related stocks
- AstraZenecaCustomer
Avidity의 올리고뉴클레오타이드 기반 항체-올리고 접합체(AOC) 플랫폼에 대한 협력/개발 파트너
- RocheCustomer
Avidity의 근이영양증 등 희귀질환 파이프라인과 관련된 잠재적 제약 협력·상업화 파트너 후보
- NovartisCompetitor
희귀근육질환 및 RNA 치료제 분야에서 경쟁하는 대형 제약사
About Avidity Biosciences
- What technical signals does Avidity Biosciences (RNA) have?
- Avidity Biosciences current technical signals: no active technical signal.
- Is Avidity Biosciences a cup-and-handle pattern?
- No. Avidity Biosciences has no valid Cup signal right now.
- What published figures are available for Avidity Biosciences?
- Market cap: $5.9B. Trailing 12 months PER: -1.4×. Latest quarter PBR: 0.63×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Avidity Biosciences, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.